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Omega-3 fatty acid (n-3 FA) deficiency is an environmental risk factor for schizophrenia,
yet characterization of the consequences of deficiency at the protein level in the brain
is limited. We aimed to identify the protein pathways disrupted as a consequence of
chronic n-3 deficiency in the hippocampus of mice. Fatty acid analysis of the hippocampus
following chronic dietary deficiency revealed a 3-fold decrease (p < 0.001) in n-3 FA
levels. Label free LC-MS/MS analysis identified and profiled 1008 proteins, of which 114
were observed to be differentially expressed between n-3 deficient and control groups
(n = 8 per group). The cellular processes that were most implicated were neuritogenesis,
endocytosis, and exocytosis, while specific protein pathways that were most significantly
dysregulated were mitochondrial dysfunction and clathrin mediated endocytosis (CME).
In order to characterize whether these processes and pathways are ones influenced
by antipsychotic medication, we used LC-MS/MS to test the differential expression of
these 114 proteins in the hippocampus of mice chronically treated with the antipsychotic
agent haloperidol. We observed 23 of the 114 proteins to be differentially expressed,
17 of which were altered in the opposite direction to that observed following n-3
deficiency. Overall, our findings point to disturbed synaptic function, neuritogenesis, and
mitochondrial function as a consequence of dietary deficiency in n-3 FA. This study greatly
aids our understanding of the molecular mechanism by which n-3 deficiency impairs
normal brain function, and provides clues as to how n-3 FA exert their therapeutic effect in
early psychosis.
Keywords: Omega-3, proteomics, neuritogenesis, mitochondrial dysfunction, clathrin mediated endocytosis,
schizophrenia
INTRODUCTION
Important new evidence indicates that dietary omega-3 fatty
acid’s (n-3 FA) significantly reduces the risk of progression
to psychosis in adolescences with at-risk mental state (ARMS)
(Amminger et al., 2010). Other studies have reported reduced
n-3 FA in red blood cell membranes, platelets, and in post-
mortem brain of patients with schizophrenia (McNamara, 2009),
and there is now strong evidence to suggest that n-3 FA defi-
ciency is a preventable risk factor for schizophrenia (McNamara,
2011). Preclinical rodent studies have demonstrated that supple-
mentation with n-3 FA can reverse stress induced behavioral and
cognitive abnormalities (Ferraz et al., 2011; Feng et al., 2012),
and even protect against MK-801 induced neurotoxicity in the
prefrontal cortex (Ozyurt et al., 2007). More recently, Bondi and
colleagues have shown that n-3 FA deficiency across consecu-
tive generations in a rat model caused impaired cognitive and
motivated behavior in adolescent rats (Bondi et al., 2013). The
consequences of dietary n-3 deficiency on molecular pathways
within the brain are relatively unexplored at the level of the
proteome.
Polyunsaturated n-3 FA, particularly docosahexaenoic acid
(DHA), are selectively concentrated within the phospholipid
bilayer of cell membrane structures in the brain (e.g., synaptic
membranes, vesicles, dendritic membranes, and mitochondria).
If unavailable, these essential polyunsaturated FA are replaced
by non-essential fatty acids, thus alterations in the membrane
microenvironment and fluidity can occur, disrupting neuronal
membrane dynamics, as well as receptor, transporter, and neuro-
transmitter function (Horrobin, 1998). Animal models have pre-
viously shown that DHA can modulate gene expression (Kitajka
et al., 2002) including enhanced dopamine receptor gene expres-
sion following maternal deficiency (Kuperstein et al., 2005).
In addition, DHA has been shown to enhance neuritogenesis
(Kawakita et al., 2006; Beltz et al., 2007; He et al., 2009), and
improve mitochondrial function in in vivo and ex vivo animal
models of neurodegenerative disease (Eckert et al., 2013). In order
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to fully understand the sub-cellular cellular processes that are
altered as a consequence of n-3 FA deficiency, we used a dis-
covery based approach to profile differential protein expression
changes within the hippocampus of mice following n-3 FA pre-
natal and trans-generational deficiency. In addition, given our
previous findings implicating the cellular trafficking process of
clathrin mediated endocytosis (CME) in schizophrenia (Föcking
et al., 2011) and evidence implicating n-3 FA in CME in cell
culture (Ben Gedalya et al., 2009), we hypothesized that n-3 defi-
ciency influences CME processes in the brain. Therefore, the
aim of this study was twofold; (1) To identify protein pathways
disrupted as a consequence of n-3 FA deficiency, and (2) To iden-
tify CME related proteins that are disrupted as a consequence
of n-3 FA deficiency. Using label free LC-MS/MS quantitative
proteomics, our investigation focused on the hippocampus from
mice chronically deficient in dietary n-3 fatty acids.
MATERIALS AND METHODS
EXPERIMENTAL DIETS AND ANIMALS
Mice were fed either an n-3 fatty acid deficient (n-3 Def) or
n-3 adequate (n-3 Adq) diet for two generations, as previously
described (Harauma and Moriguchi, 2011). The experimental
diets were based on the AIN-93G diet recommendations for
rodents (Reeves et al., 1993), with modifications of the fat source
(flaxseed oil) to achieve the low n-3 fatty acid level required
(Table 1). The fat content in both diets was 5% (w/w) diet, and
there was no difference in the total n-6 fatty acids between the
two diets. The diet was custom prepared at Oriental Yeast, Chiba,
Japan.
Female CD-1 (ICR) mice were obtained at 3 weeks of age
from Charles River Japan, Inc. and fed an n-3 Def or n-3 Adq
diet. Animals were maintained within the animal facility under
conventional conditions, as previously described (Harauma and
Moriguchi, 2011). At 8 weeks of age, they were mated with
9-week-old males of the same strain. Their litters (1st generation)
were culled to ten pups and the pups were weaned onto the same
diet as their Dams. The male and female offspring (2nd genera-
tion) weremaintained on each diet.When they were 10 weeks old,
brain was collected, and the hippocampus was dissected from the
whole brain and frozen at −80◦C prior fatty acid analysis. This
experimental protocol was approved by the audit committee of
Azabu University Animal Experiment, according the guidelines
of the Animal Experiment in Azabu University.
To confirm n-3 deficiency in brain tissue, lipid extraction and
gas chromatography was carried out as previously described in
(Harauma and Moriguchi, 2011), according to the method of
Lepage and Roy (1986). Internal standards were used to calcu-
late tissue fatty acid concentration. All data were expressed as
the mean ± Standard Error of the Mean (SEM). The fatty acid
composition in the hippocampus tissues were evaluated using
the Tukey’s test after One-Way ANOVA (Statistica, Statsoft Japan,
Tokyo, Japan) at P < 0.05.
SAMPLE PREPARATION AND LABEL FREE QUANTIFICATION USING
LC-MS/MS ANALYSIS
For label free LC-MS/MS analysis, the hippocampus of 16 n-3 Def
and 16 n-3 Adq samples per dietary group were assessed. Prior to
analysis, these 16 samples were sub-pooled according to gender (4
male and 4 female per dietary group) so that 8 × n-3 Def and 8×
n-3 Adq LC-MS/MS runs were performed. Following solubilisa-
tion of samples by sonication in triethylammonium bicarbonate
(TEAB; Sigma), 50μg of protein from each of the 8 n-3 Adq
and 8n-3 Def samples was denatured for 10min at 80◦C in the
presence of 1% RapiGest (Waters). Samples were reduced with
TCEP (50mM) for 60min at 60◦C, followed by alkylation with
Iodoacetamide (200mM) for 30min in the dark. Digestion with
trypsin (Promega; 1μg/μl) was carried out overnight at 37◦C, and
Tryptic peptides were purified using ZipTips (Millipore) accord-
ing to the manufacturer’s instructions. Samples were resuspended
in Solution A (HPLC grade water, 2% acetonitrile, 0.5% acetic
acid) where by 1μg of protein digest (5μl) was injected per LC-
MS/MS run. Each of the 16 samples were run in triplicate, on a
Thermo Scientific LTQ ORBITRAP XL mass spectrometer con-
nected to an Dionex Ultimate 3000 (RSLCnano) chromatography
system. Each sample was loaded onto Biobasic Picotip Emitter
(120mm length, 75μm ID) packed in house with Reprocil Pur
C18 (1.9μm) reverse phase media column, and was separated by
an increasing acetonitrile gradient, using a 56min reverse phase
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Table 1 | Composition of experimental diets.
Composition (g/100g)
n-3 Adq. n-3 Def.
Casein, vitamin free 20 20
Carbohydrate: 65 65
Cornstarch 10 10
α-Cornstarch 15 15
Sucrose 10 10
Glucose 20 20
Dextrose 5 5
Maltose-dextrin 5 5
Cellulose 5 5
Mineral-salt mix 3.5 3.5
Vitamin mix 1 1
L-Cystine 0.3 0.3
Choline bitartrate 0.25 0.25
TBHQ 0.001 0.001
Fat: 5 5
Hydrogenated coconut oil 3.875 4.05
Saffower oil 0.885 0.95
Flaxseed oil 0.24 none
Fatty acid compositiona
Saturates 75.1 78.1
Monounsaturates 5.4 4.7
18:2n-6 14.6 14.6
18:3n-3 2.53 0.25
n-6/n-3 5.8 58.5
The two experimental diets, an n-3 fatty acid dequate diet (n-3 Adq) and an n-3
fatty acid deficient diet (n-3 Def), were based on the AIN-93 formulation with
several modifications to obtain the extremely low basal level of n-3 fatty acid
required in this study.
aThe 20:4n-6, 20:5n-3 and 22:6n-3 fatty acids were less than 0.01%, i.e., not
detected (nd).
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gradient at a flow rate of 250 nL/min. From 0 to 7min 5μl (1μg)
of sample was injected and loaded onto the column at a flow rate
of 1.5μl/min. At 7min the mass spectrometer started to acquire
data, the chromatography gradient continued, 7–44min from
5 to 35% Solution B (acetonitrile containing 3% HPLC grade
water and 0.5% acetic acid) at 250 nl/min, 44–50min from 35 to
90% Solution B at 250 nl/min, 50–55min at 90% Solution B at
250 nl/min increasing to 900 nl/min, 55–56min at 90% Solution
B to 2% Solution B at 900 nl/min decreasing to 250 nl/min. The
mass spectrometer was operated in positive ion mode with a cap-
illary temperature of 200◦C, a capillary voltage of 45V, a tube lens
voltage of 100V and with a potential of 1800V applied to the frit.
Survey full-scan MS spectra (300–2000Da) were acquired in the
Orbitrap with a resolution of 60,000, whereby the FTMS maxi-
mum injection time was 700ms, the Ion trap injection time was
100ms, and the 7 most intense ions from the preview scan were
selected for MS/MS analysis.
DATA ANALYSIS
Label-free quantification (LFQ) was performed with Max Quant
(V 1.3.0.2) as previously described (Hubner et al., 2010).
Methionine oxidations and acetylation of protein N-termini were
specified as variable modifications, while carbamidomethylation
was specified as a fixed modification, and 2 miscleavages were
allowed. Protein and peptide FDR’s were set to 0.01. Only proteins
with at least two peptides (one uniquely assignable to the protein)
were considered as reliably identified. LFQ intensity values were
used for protein quantification between groups. Only unique and
razor peptides were considered for quantification with a mini-
mum ratio count of. Statistical analyses was performed in Perseus
(V 1.3.0.4), whereby the data was log 2 transformed, missing val-
ues were replaced by values form the normal distribution, and
column normalization was performed by subtracting the median.
Student’s t-test was applied to identify proteins differentially
expressed between groups at a 5% threshold, and a permutation-
based FDR was applied at a 5% threshold. Ingenuity Pathway
Analysis (IPA; www.ingeunity.com) was performed on all statis-
tically significant proteins. The IPA p-value was calculated using
the right-tailed Fisher’s Exact Test and multiple hypothesis cor-
rection was based on the Benjamini-Hochberg (B-H) approach at
1% FDR threshold.
HALOPERIDOL TREATED MICE
In order to assess the effects of psychotropic medication on
the expression of the specific candidate proteins identified as
altered as a consequence of n-3 deficiency, hippocampal tis-
sue was harvested from C57BL6 mice chronically treated with
haloperidol (28 days), as previously described (Föcking et al.,
2011). Ethical approval (application no.175) was granted by the
Royal College of Surgeons in Ireland Research Ethics Committee.
The tissue was processed and analyzed by LC-MS/MS as
above.
RESULTS
ANIMALS AND FATTY ACID ANALYSIS OF BRAIN TISSUE
The diets produced no significant differences in body weight gain
between dietary groups. In the fatty acid composition analysis
of the hippocampus, total n-3 fatty acids were significantly
decreased in the n-3 Def group (p < 0.001), in each gender
(Table 2). This decrease is mostly attributed the reduced levels
of docosahexaenoic acid (DHA; 22:6n-3; Table 2). Saturated and
monounsaturated fatty acid were approximately the same level.
It is noteworthy that the levels of omega-6 fatty acids (n-6 FA)
such 22:4n-6 and 22:5n-6 are considerably increased in the n-
3 Def mice. It is well-documented that in the absence of n-3
fatty acids, the brain replaces them with other long chain fatty
acids such as 22:4n-6 and 22:5n-6, and these findings are in keep-
ing with previous fatty acid composition analyses from n-3 FA
deficient mice (Moriguchi et al., 2000; Harauma and Moriguchi,
2011).
LABEL FREE LC-MS/MS QUANTITATIVE ANALYSIS
For label free LC-MS/MS, we assessed the hippocampus of
8 samples per dietary group, including 4 male (sub-pool of
8 mice) and 4 female (sub-pool of 8 mice) in each group.
To account for technical variability and reduce the risk of
detecting false positives, samples were run in triplicate on
the Thermo LTQ Orbitrap. The average MS1 peak width was
30 s, and the scan time ranged between 1 and 2 s, whereby
an average of 15 data points were acquired for quantitation
(Supplementary Figure S1). Using Max Quant we identified and
quantified 1008 proteins for differential expression between the 8
n-3 Def and 8 n-3 Adq samples of the hippocampus. Expression
profiling identified 114 proteins as significantly differentially
expressed (p < 0.05) between the dietary groups (student’s t-
test). Of these, 61 proteins were significantly increased, and
53 proteins were significantly decreased in expression. Six pro-
teins were significant following permutation-based FDR at 5%
threshold. Supplementary Table S1 lists the proteins significantly
altered as a consequence of dietary n-3 deficiency in the hip-
pocampus, and proteins that remained significant following FDR
are marked with an asterisks.
PATHWAY ANALYSIS
Using IPA we identified cellular function and maintenance as
the most significant function disrupted in n-3 FA deficiency
(Supplementary Figure S2, Supplementary Table S2). The sub-
categories within this process included endocytosis (12 proteins),
neuritogenesis (15 proteins), and exocytosis (6 proteins) func-
tions as detailed in Table 3. In addition, IPA reported the top
canonical pathways altered as a consequence of n-3 deficiency
(Figure 1, Table 4). These were mitochondrial dysfunction (10
proteins), CME (10 proteins), and 14-3-3 signaling (6 pro-
teins) pathways. Canonical pathways within the IPA knowledge
have a defined number of molecules, and a ratio to the total
number of molecules in the pathway is reported, as well as
a B-H p-value. IPA identified 49 of the 114 proteins as pre-
viously implicated in neurological disease at the mRNA level
(Supplementary Table S1).
CANDIDATE PROTEIN CHANGES IN HALOPERIDOL TREATED MICE
We examined the hippocampal protein profile from mice chron-
ically treated with haloperidol for the 114 candidate proteins
identified to be differentially expressed following n-3 deficiency.
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Table 2 | Fatty acid composition of the hippocampus.
Fatty acid n-3 Def n-3 Adq
Male (n = 5) Female (n = 6) Male (n = 7) Female (n = 6)
14:0 0.11±0.003 0.12±0.01 0.12±0.01 0.12±0.01
16:0 DMA 2.12±0.04 2.00±0.04 1.98±0.03 1.99±0.02
16:0 19.89±0.30 19.47±0.21 19.27±0.19 19.29±0.32
18:0 DMA 3.38±0.07 3.31±0.06 3.61±0.03 3.59±0.06**
18:0 20.80±0.13 20.99±0.03 21.01±0.14 21.64±0.24
20:0 0.28±0.02 0.29±0.02 0.32±0.02 0.30±0.02
22:0 0.44±0.05 0.46±0.03 0.50±0.04 0.46±0.05
23:0 0.11±0.01 0.10±0.01 0.12±0.01 0.10±0.03
24:0 0.61±0.07 0.61±0.06 0.51±0.07 0.40±0.11
Total Sat. 47.73±0.18 47.35±0.19 47.44±0.13 47.90±0.33
16:1n-7 0.21±0.02 0.26±0.01 0.20±0.02 0.20±0.02
18:1 DMA 1.11±0.06 1.18±0.04 1.22±0.05 1.09±0.06
18:1n-7 3.31±0.04 3.34±0.03 3.16±0.03* 2.94±0.04***,##
18:1n-9 11.44±0.21 11.76±0.16 12.14±0.17 12.10±0.27
20:1n-9 0.78±0.06 0.82±0.05 0.98±0.09 0.91±0.10
22:1n-9 0.12±0.01 0.15±0.02 0.16±0.02 0.13±0.04
24:1n-9 1.11±0.14 1.19±0.09 1.35±0.15 1.25±0.16
Total Mono. 18.07±0.43 18.71±0.14 19.21±0.23 18.62±0.60
18:2n-6 0.26±0.004 0.28±0.01 0.32±0.01** 0.30±0.02
20:2n-6 0.23±0.01 0.17±0.01 0.23±0.01 0.18±0.01
20:3n-6 0.30±0.02 0.25±0.02 0.46±0.03** 0.43±0.03***
20:4n-6 11.64±0.12 10.63±0.49 10.50±0.14* 10.57±0.16
22:2n-6 0.11±0.01 0.11±0.02 0.11±0.01 0.07±0.02*
22:4n-6 3.63±0.08 3.37±0.06 2.58±0.09*** 2.69±0.04***
22:5n-6 10.40±0.26 10.30±0.59 0.78±0.05*** 0.76±0.04***
Total n-6 PUFA 26.56±0.30 25.11±0.25# 14.92±0.22*** 15.01±0.18***
22:5n-3 0.07±0.003 0.04±0.02 0.16±0.01* 0.12±0.03
22:6n-3 4.64±0.04 5.50±0.32 15.46±0.35*** 15.75±0.34***
Total n-3 PUFA 4.71±0.04 5.54±0.32 15.62±0.35*** 15.88±0.31***
Total fatty acids (μg/mg wet wt) 39.11±3.98 34.22±1.45 36.51±2.43 39.48±2.67
Fatty acid methyl esters from 10:0 to 24:1n-9 were analyzed. 10:0, 12:0, 12:1, 14:1, 18:3n-6, 18:3n-3, 20:3n-3, and 20:5n-3 were not detected (nd, i.e., < 0.01%).
Each parameter is presented as the mean ± S.E.M. *P < 0.05, **P < 0.01, ***P < 0.001: compared between n-3 Def and n-3 Adq diet group in each gender.
#P < 0.05, ##P < 0.01: compared between male and female in each diets (One-Way ANOVA and Tukey test.).
Table 3 | The cellular function and maintenance categories disrupted as a consequence of n-3 FA deficiency in order of significance.
Cellular
function
p-Value Molecules No.
Molecules
and
maintenance
Endocytosis 1.79E-04 APOE,ATP5B,CAP1,CLTC,DNM1L,GRB2,HSPA8,MYO5A,PIP5K1C,PPP3CB,RHOB,SH3GL2 12
Neuritogenesis 4.05E-04 ABI2,APOE,CTNNA2,DNM1L,GJA1,MYO5A,PIP5K1C,RAB3A,RALA,RHOB,RTN3,RTN4,SEPT11,STMN1,VAPA 15
Exocytosis 3.89E-02 DNM1L,MYO5A,PIP5K1C,RAB3A,RALA,SRCIN1 6
These sub-categories include endocytosis, neuritogenesis, and exocytosis functions.
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FIGURE 1 | The top IPA canonical pathways disrupted as a consequence of n-3 FA deficiency. These pathways included mitochondrial dysfunction, CME,
14-3-3 mediated signaling, ERK,/MAPK signaling, mTor, and EIF2 signaling.
Table 4 | The top IPA canonical pathways disrupted as a consequence of n-3 FA deficiency.
Ingenuity canonical pathways -log(B-H
p-value)
Ratio Molecules
Mitochondrial dysfunction 4.21E00 10/174 (0.057) PDHA1,NDUFV1,ATP5B,ATP5A1,OGDH,UQCRC1,
UQCRC10, NDUFA13,COX4I1,NDUFA8
Clathrin-mediated endocytosis 4.21E00 10/196 (0.051) HSPA8,APOE,PPP3CB,ARPC5L,GRB2,PIP5K1C,CLTC,SH3GL2,DNM1L,UBC
14-3-3-mediated Signaling 3.06E00 7/121 (0.058) YWHAQ,TUBA1A,YWHAE,GRB2,YWHAZ,TUBA4A,PRKCE
ERK/MAPK signaling 2.23E00 7/206 (0.034) YWHAQ,GRB2,PPP2R4,YWHAZ,PRKAR2A,PRKACA, PRKCE
mTOR signaling 2.21E00 7/210 (0.033) RPS4Y1,RPS3A,RHOB,PPP2R4,RPS18,PRKCE,RPS25
EIF2 signaling 1.65E00 6/200 (0.03) RPS4Y1,RPS3A,GRB2,RPS18,RPS25,RPLP0
This table corresponds to Figure 1, and list the proteins implicated in mitochondrial dysfunction, CME, 14-3-3 mediated signaling, ERK,/MAPK signaling, mTor, and
EIF2 signaling.
We used the same LC-MS/MS platform described above. Twenty-
three of the 114 n-3 candidate proteins were identified as differ-
entially expressed in the haloperidol treated animals and of these,
17 of which were significantly altered in the opposite direction to
that observed in n-3 deficiency (Supplementary Table S1).
DISCUSSION
We used label free LC-MS/MS to study the consequences of n-3
FA deficiency on protein expression in the hippocampus of mice.
We profiled 1008 proteins for differential expression, and iden-
tified 114 proteins as significantly altered between n-3 deficient
and control groups. The major biological processes disturbed by
n-3 deficiency included endocytosis, neuritogenesis, and exocy-
tosis (Table 3), and the major signaling pathways altered were
mitochondrial dysfunction, CME, 14-3-3 signaling (Table 4).
Synaptic function was thus significantly implicated as a biolog-
ical process (endocytosis and exocytosis) and pathway (CME),
followed by disturbances in neuritogenesis, mitochondrial dys-
function, and 14-3-3 signaling. As these functions have previously
been reported to be abnormal in schizophrenia (Harrison and
Weinberger, 2005; English et al., 2011, 2012; Kim et al., 2012;
Manji et al., 2012), our data is consistent with the view that n-
3 deficiency is an environmental risk factor for schizophrenia
(McNamara, 2011).
Synaptic function was significantly disturbed with alternations
in both endocytosis (12 proteins) and exocytosis (6 proteins)
functions in the hippocampus of n-3 FA deficient mice. More
specifically, and in keeping with our hypothesis, the CME pro-
tein pathway was implicated, with 6 proteins decreased (↓ GRB2,
↓ PIP5K1C, ↓ APOE, ↓ DNM1L, ↓ PPP3CB, ↓ ARPC5L), and 4
increased (↑ CLTC, ↑ HSPA8, ↑ UBC, ↑ SH3GL2) in expression.
CME is the best-characterized endocytotic pathway for cellu-
lar membrane and protein trafficking, and post-mortem studies
implicate CME as one a potential core pathophysiological pro-
cesses in schizophrenia (Schubert et al., 2012). Two of the above
CME proteins, CLTC (Allen et al., 2008) and HSPA8 (Föcking
et al., 2011), have previously been implicated in schizophre-
nia. In keeping with our data, Ben Gedalya and colleagues
have previously shown that n-3 FA augmentation are capable of
enhancing CME in neuronal cultured cells (Ben Gedalya et al.,
2009). Other endocytosis (↑ RHOB, ↑ MYO5A, ↑ ATP5B, ↓
CAP1), and exocytosis (RAB3A, SRCIN1, RALA) proteins were
also significantly altered, along with SNARE protein SNAP 47
(↑2.1 fold). In addition, the post synaptic density (PSD) pro-
tein SHANK3 was significantly increased (↑1.68 fold) in expres-
sion. SHANK3 is a major susceptibility gene in schizophrenia
(Gauthier et al., 2010) and we have recently observed decreased
SHANK3 expression in the PSD in schizophrenia (Föcking et al.,
2012). As disturbed CME and synaptic processes are core features
in the pathophysiology of psychiatric disorders, this study pro-
vides further evidence that n-3 FA deficiency is a risk factor for
schizophrenia.
www.frontiersin.org October 2013 | Volume 4 | Article 208 | 5
English et al. Omega-3 fatty acid deficiency in the hippocampus
Neuritogenesis was the second most significant function
implicated following n-3 FA deficiency with 6 proteins sig-
nificantly decreased (↓SEPT11, ↓PIP5K1C, ↓APOE, ↓VAPA,
↓RALA, ↓DNM1L), and 9 increased (↑RAB3A, ↑STMN1,
↑GJA1, ↑ABI2, ↑RTN3, ↑RTN4, ↑CTNNA2, ↑MYO5A,
↑RHOB) in expression. Seven neuritogenesis proteins have
roles in dendritic growth and branching (↓SEPT11, ↓APOE,
↓DNM1L, ↑CTNNA2, ↑MYO5A, ↑RHOB, ↑RTN4) and one of
these RTN4 (↑1.76 fold) a potent neurite outgrowth inhibitor
(Chen et al., 2000). CTNNA2 (↑1.5 fold) is a schizophrenia
susceptibility gene (Chu and Liu, 2010), and functions in den-
drite morphogenesis, cell adhesion, and regulation of synaptic
structural plasticity and has recently been implicated in a
pluripotent stem cell model of schizophrenia (Pedrosa et al.,
2011). SEPT11 (↓1.6 fold) has previously been observed to be
reduced in the hippocampus in schizophrenia (Föcking et al.,
2011). Importantly, six of the neuritogenesis proteins implicated
here (SEPT11, RHOB, RALA, DNM1L, RTN4, MYO5A), have
expression changes consistent with decreased neuritogenesis
(Chen et al., 2000; Rao et al., 2002; Lalli and Hall, 2005; Li et al.,
2009; McNair et al., 2010; Dickey and Strack, 2011), suggesting
that neuritogenesis is reduced as a consequence of n-3 FA
deficiency. These findings are in keeping with previous studies
that show enhanced hippocampal neuritogenesis following DHA
supplementation (Kawakita et al., 2006; Beltz et al., 2007; He
et al., 2009).
Mitochondrial dysfunction is described in Alzheimer’s,
Huntington’s, and Parkinson’s disease (Eckert et al., 2013),
and there is now increasing evidence implicating mito-
chondrial dysfunction in schizophrenia and mood disor-
ders (Martins-De-Souza et al., 2011; Manji et al., 2012).
Mitochondrial dysfunction occurs when the antioxidant defence
system is overpowered by ROS-mediated oxidative stress,
triggered by factors such as genetic defects, environmen-
tal exposures, and metabolic fluctuations. In the current
study, we observed 10 mitochondrial dysfunction proteins to
be significantly increased by n-3 FA deficiency (↑ATP5A1,
↑ATP5AB, ↑COX4I1, ↑NDUFA8, ↑NDUFA13, ↑NDUFV1,
↑OGDH, ↑PDHA1, ↑UQCRC1, ↑UQCR10). This uniform and
significant up-regulation of mitochondrial dysfunction suggests
n-3 FA deficiency is an environmental risk factor (dietary intake)
capable of triggering cellular oxidative stress. In addition, mito-
chondria have important roles in regulating synaptic plastic-
ity, learning, and memory, due to their key roles in processes
such as ATP production (Manji et al., 2012), Ca2+ homeosta-
sis (Gleichmann and Mattson, 2011), AMPA receptor trafficking
in the synaptic membrane (Li et al., 2010), and apoptosis (Youle
and Strasser, 2008), the latter of which is particularly important
during neurogenesis (Deng et al., 2010). Dysfunctions in these
processes are important neuropathological features of neurode-
generative and psychiatric diseases, and indeed 7 of the 10 sig-
nificant mitochondrial proteins have previously been implicated
at the mRNA level in either Alzheimer’s, Huntington disease, or
schizophrenia (Supplementary Table S1). In addition, ATP5A1
has previously been identified as significantly increased in pro-
teomic studies of post-mortem brain in schizophrenia (English
et al., 2011) and bipolar disorder (Pennington et al., 2008). In
support of these findings, in vivo and ex vivo animal studies
showed an improvement in mitochondrial function after treat-
ment with n-3 FA (Eckert et al., 2013); and more specifically
augmentation with DHA improved mitochondrial ATP gener-
ation in the CA1 area of the hippocampus (Harbeby et al.,
2012). Moreover, a recent study by Feng and colleagues found
that maternal DHA supplementation protects against prenatal
stress induced impairment of learning and memory, and nor-
malized mitochondrial, apoptotic, and oxidative stress proteins
altered as a consequence of prenatal stress (Feng et al., 2012). The
ability of dietary n-3 FA to consistently and uniformly modulate
mitochondrial function may thus be instrumental in improv-
ing cognitive and behavioral abnormalities, as well as providing
neuroprotection in vulnerable diseases states. In addition, 14-3-3
signaling pathway was also increased by deficiency, with 7 pro-
teins up-regulated (↑PRKCE, ↑TUBA1A, ↑TUBA4A, ↑GRB2,
↑YWHAE, ↑YWHAQ, ↑YWHAZ). The 14-3-3 proteins are con-
sistently implicated in schizophrenia proteomic studies (English
et al., 2011), but not specifically (Zabel et al., 2008), and have
a wide variety of functions including cell cycle control, cellular
signaling, and stress response.
The expression of the 114 candidate proteins were examined
following chronic treatment with the antipsychotic haloperidol
in the hippocampus. Twenty-three of the 114 proteins were sig-
nificantly altered by haloperidol treatment and of these 17 were
differentially expressed in the opposite direction to that observed
following n-3 FA deficiency. These included proteins involved
in neuritogenesis (↓CTNNA2, ↓STMN1), mitochondrial dys-
function (↓ATP5A1, ↓ATP5B, ↓UQCRC1), CME (↑ARPCL5,
↓HSPA8), ribosomal proteins (↑RPS18, ↑RPS3A), and others
(↑ARL3, ↑CASKIN1, ↓GDI2, ↓NSFL1C, ↓PKM2, ↓PRKACA,
↓PYGB) as detailed in Supplementary Table S1. These findings
provide preliminary evidence that antipsychotic drug treatment
and n-3 FA deficiency share differential expression of several pro-
tein, and this evidence provides clues as to the that pathways that
may be implicated in disease pathology.
This study has limitations and we acknowledge that the major
findings were not validated by traditional methods such as west-
ern blotting or ELISA. However, our quantification method was
based on triplicate LC-MS/MS runs for each sample, a strat-
egy that was not feasible in previous 2D gel based experiments.
In addition, reliability and consistency was confirmed by visual
inspection of spectra, trypsin autolysis peaks, and stable LC-
MS/MS retention times across runs (data not shown). Total pep-
tide count (no. of peptides identified per protein) were checked
for consistency within replicate runs, and across samples to ensure
the quality of the data. It should also be noted that our model of
deficiency, through 2 generations, maybe considered extreme but
previous work in these animals had demonstrated greater learn-
ing and cogitative defects in the second generation, as well as
alterations in dopamine availability, respectively (Moriguchi et al.,
2000; Bondi et al., 2013).
This is the first study to extensively characterize the pro-
teomic and molecular pathways disturbed in the hippocampus as
consequence of n-3 FA deficiency. In light of this data, it is con-
ceivable that abnormalities of synaptic function, neuritogenesis,
and mitochondrial dysfunction exists in individuals chronically
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deficient in n-3 FA, and that the modulation of these pro-
cesses are a mechanisms by which n-3 FA improve symptoms
in subjects in the at risk mental state (Amminger et al., 2010).
This suggestion is in keeping with findings that neuritogene-
sis (Kawakita et al., 2006; Beltz et al., 2007; He et al., 2009)
and mitochondrial function (Eckert et al., 2013) are signif-
icantly improved following n-3 augmentation, including that
following prenatal stress (Feng et al., 2012), and these changes
coincided with improvements in cognitive and depressive-like
behaviors. Future studies will focus on understanding the brain
proteomic response to n-3 FA supplementation following defi-
ciency, and indeed by studying sub-proteomes such as membrane
proteins (English et al., 2012) in n-3 deficient or n-3 ameliorated
states.
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Supplementary Table S1 | List of 114 proteins significantly differentially
expressed as a consequence of dietary n-3 deficiency in the
mouse hippocampus. The table is ordered p-value, and proteins that were
significant after permutation based FDR at 5% threshold are marked with
an ∗. Further details on fold change, protein name, and the fold change of
proteins that were significant in the haloperidol treated mouse
hippocampus are also provided for each protein entry. In addition, IPA
information on the most significant canonical pathways and neurological
diseases are included.
Supplementary Figure S1 | (A) Representative MS1 peak which eluted at
12.75minutes, with a m/z of 628.82. The peak width ranged between
12.41 and 12.92min with at least 15 data points acquired across the 30 s
peak. (B) Representative MS1 peak which eluted at 19.93min, with a m/z
of 360.72. The peak width ranged between 19.76 and 20.30min with at
least14 data points acquired across the 30 s peak. (C) Representative
MS1 peak which eluted at 22.86min, with a m/z of 528.26. The peak
width ranged between 22.56 and 23.13min with at least 23 data points
acquired across the 30 s peak.
Supplementary Figure S2 | The top IPA biological functions disrupted as a
consequence of n-3 FA deficiency.
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